| GENERIC NAME | This data is not available for free |
| STRUCTURE |
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3- [(4-pyridin-3-ylpyrimidin-2-yl)amino]-phenyl]- benzamide |
| INDICATION'S |
ONCOLOGY - Chronic Myeloid Leukemia - GastroIntestinal Stromal Tumors |
| MARKETER'S COUNTRY | USA |
| MECHANISM OF ACTION | Bcr-Abl Tyrosine Kinase Inhibition |
| STATUS | Approved. US Patent Expiration Date: 01.04.2015 |
| COMPANY | This data is not available for free |
| PATENT NUMBER | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |